EC Number |
Inhibitors |
Structure |
---|
3.4.22.B62 | 3-methyl-N-phenyl-7-([4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl]methyl)quinoxaline-2-carboxamide 1,4-dioxide |
49% inhibiton at 0.01 mM |
|
3.4.22.B62 | 3-methyl-N-phenylquinoxaline-2-carboxamide 1,4-dioxide |
40% inhibiton at 0.01 mM |
|
3.4.22.B62 | 4-(2,5-dimethyl-1H-pyrrol-1-yl)-N'-(5-methyl-3-phenyl-1,2-oxazole-4-carbonyl)benzohydrazide |
- |
|
3.4.22.B62 | 4-[4-(benzyloxy)phenyl]-3-([(4-methylphenyl)methyl]sulfanyl)-4,5-dihydro-1H-1,2,4-triazol-5-one |
- |
|
3.4.22.B62 | 6,7-dichloro-2-methyl-3-(phenylsulfanyl)quinoxaline 1,4-dioxide |
22% inhibiton at 0.01 mM |
|
3.4.22.B62 | 6-[(E)-[(2Z)-[4-(4-chlorophenyl)-3-(prop-2-en-1-yl)-1,3-thiazol-2(3H)-ylidene]hydrazinylidene]methyl]-2,3-dimethylquinoxaline 1,4-dioxide |
2% inhibiton at 0.01 mM |
|
3.4.22.B62 | 6-[(E)-[(2Z)-[4-oxo-3-(prop-2-en-1-yl)-1,3-thiazolidin-2-ylidene]hydrazinylidene]methyl]-N,3-diphenylquinoxaline-2-carboxamide 1,4-dioxide |
81% inhibiton at 0.01 mM |
|
3.4.22.B62 | 7-[ethyl[(2E)-3-phenylprop-2-en-1-yl]amino]-3-methyl-N-phenylquinoxaline-2-carboxamide 1,4-dioxide |
54% inhibiton at 0.01 mM |
|
3.4.22.B62 | cathepsin K inhibitor II |
i.e. Z-LNHNHCONHNHLF-Boc |
|
3.4.22.B62 | E-64 |
- |
|